Ticker brief
ALVO ALVOTECH SA
Consumer, Non-cyclical · Biotechnology
last close
$4.58
1 day
-4.4%
14 days
-20.8%
mkt cap
·
signals 14d
5
authors 14d
5
crowd 14d
+0.0σ
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-14 · now -0.10 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @dmdt14 | C | -0.48 | 1 | +0.50 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @UTEX_io | C | +0.04 | 1 | +0.50 |
| @oratnek_ill | C | -0.96 | 1 | +0.20 |
| @BiopharmIQ | B | · | 1 | -0.10 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @BiopharmIQ | -0.10 | Lists opening price moves and biotech news catalysts; output is capped at the first six tickers. | -11.4% | tweet ↗ |
| 2026-10-06 | @oratnek_ill | +0.20 | Daily watchlist ranks technical setups without expressing entry intent. | -25.4% | tweet ↗ |
| 2026-10-05 | @UTEX_io | +0.50 | FDA approved additional US manufacturing capacity for Alvotech's Simlandi biosimilar. | -25.0% | tweet ↗ |
| 2026-10-05 | @OpenOutcrier | +0.50 | FDA approved additional US manufacturing capacity for Alvotech's Humira biosimilar. | -25.0% | tweet ↗ |
| 2026-10-05 | @dmdt14 | +0.50 | ALVO received FDA manufacturing approval; APLD is separately flagged ahead of Oct. 7 earnings. | -25.0% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.